Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma

Lihua Hu, Jingpeng Liu, Zhi Li, Chunling Wang, Ali Nawshad

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective During the development of oral squamous cell carcinoma (OSCC), the transformed epithelial cells undergo increased proliferation resulting in tumor growth and invasion. Interestingly, throughout all phases of differentiation and progression to OSCC, transforming growth factor-β1 (TGF)-β1 induces cell cycle arrest or apoptosis; however, the role of TGF-β1 in promoting cancer cell proliferation has not been explored in detail. The purpose of this study was to identify the effect of TGF-β1 on OSCC cell proliferation. Study Design Using both human OSCC samples and cell lines (UMSCC38 and UMSCC11B), we assessed protein, mRNA, gene expression, and protein–DNA interactions during OSCC progression. Results Our results showed that TGF-β1 increased OSCC cell proliferation by upregulating the expression of ΔNp63 and c-Myc oncogenes. Although the basal OSCC cell proliferation is sustained by activating ΔNp63, increased induction of c-Myc causes unregulated OSCC cell proliferation. Following induction of the cell cycle by ΔNp63 and c-Myc, cancer cells that halt c-Myc activity undergo epithelial mesenchymal transition or invasion while those that continue to express ΔNp63/c-Myc undergo unlimited progression through the cell cycle. Conclusions OSCC proliferation is manifested by the induction of c-Myc in response to TGF-β1 signaling, which is essential for OSCC growth. Our data highlight the potential role of TGF-β1 in the induction of cancer progression and invasion of OSCC.

Original languageEnglish (US)
Pages (from-to)460-482.e4
JournalOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Volume122
Issue number4
DOIs
StatePublished - Oct 1 2016

Fingerprint

Transforming Growth Factors
Squamous Cell Carcinoma
Cell Proliferation
Neoplasms
Cell Cycle
myc Genes
Epithelial-Mesenchymal Transition
Growth
Cell Cycle Checkpoints
Epithelial Cells
Apoptosis
Gene Expression
Cell Line
Messenger RNA

ASJC Scopus subject areas

  • Surgery
  • Oral Surgery
  • Pathology and Forensic Medicine
  • Dentistry (miscellaneous)
  • Radiology Nuclear Medicine and imaging

Cite this

Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma. / Hu, Lihua; Liu, Jingpeng; Li, Zhi; Wang, Chunling; Nawshad, Ali.

In: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Vol. 122, No. 4, 01.10.2016, p. 460-482.e4.

Research output: Contribution to journalArticle

@article{e4383a494ad34bd0adf05e8179448e2e,
title = "Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma",
abstract = "Objective During the development of oral squamous cell carcinoma (OSCC), the transformed epithelial cells undergo increased proliferation resulting in tumor growth and invasion. Interestingly, throughout all phases of differentiation and progression to OSCC, transforming growth factor-β1 (TGF)-β1 induces cell cycle arrest or apoptosis; however, the role of TGF-β1 in promoting cancer cell proliferation has not been explored in detail. The purpose of this study was to identify the effect of TGF-β1 on OSCC cell proliferation. Study Design Using both human OSCC samples and cell lines (UMSCC38 and UMSCC11B), we assessed protein, mRNA, gene expression, and protein–DNA interactions during OSCC progression. Results Our results showed that TGF-β1 increased OSCC cell proliferation by upregulating the expression of ΔNp63 and c-Myc oncogenes. Although the basal OSCC cell proliferation is sustained by activating ΔNp63, increased induction of c-Myc causes unregulated OSCC cell proliferation. Following induction of the cell cycle by ΔNp63 and c-Myc, cancer cells that halt c-Myc activity undergo epithelial mesenchymal transition or invasion while those that continue to express ΔNp63/c-Myc undergo unlimited progression through the cell cycle. Conclusions OSCC proliferation is manifested by the induction of c-Myc in response to TGF-β1 signaling, which is essential for OSCC growth. Our data highlight the potential role of TGF-β1 in the induction of cancer progression and invasion of OSCC.",
author = "Lihua Hu and Jingpeng Liu and Zhi Li and Chunling Wang and Ali Nawshad",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.oooo.2016.05.018",
language = "English (US)",
volume = "122",
pages = "460--482.e4",
journal = "Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology",
issn = "2212-4403",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma

AU - Hu, Lihua

AU - Liu, Jingpeng

AU - Li, Zhi

AU - Wang, Chunling

AU - Nawshad, Ali

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Objective During the development of oral squamous cell carcinoma (OSCC), the transformed epithelial cells undergo increased proliferation resulting in tumor growth and invasion. Interestingly, throughout all phases of differentiation and progression to OSCC, transforming growth factor-β1 (TGF)-β1 induces cell cycle arrest or apoptosis; however, the role of TGF-β1 in promoting cancer cell proliferation has not been explored in detail. The purpose of this study was to identify the effect of TGF-β1 on OSCC cell proliferation. Study Design Using both human OSCC samples and cell lines (UMSCC38 and UMSCC11B), we assessed protein, mRNA, gene expression, and protein–DNA interactions during OSCC progression. Results Our results showed that TGF-β1 increased OSCC cell proliferation by upregulating the expression of ΔNp63 and c-Myc oncogenes. Although the basal OSCC cell proliferation is sustained by activating ΔNp63, increased induction of c-Myc causes unregulated OSCC cell proliferation. Following induction of the cell cycle by ΔNp63 and c-Myc, cancer cells that halt c-Myc activity undergo epithelial mesenchymal transition or invasion while those that continue to express ΔNp63/c-Myc undergo unlimited progression through the cell cycle. Conclusions OSCC proliferation is manifested by the induction of c-Myc in response to TGF-β1 signaling, which is essential for OSCC growth. Our data highlight the potential role of TGF-β1 in the induction of cancer progression and invasion of OSCC.

AB - Objective During the development of oral squamous cell carcinoma (OSCC), the transformed epithelial cells undergo increased proliferation resulting in tumor growth and invasion. Interestingly, throughout all phases of differentiation and progression to OSCC, transforming growth factor-β1 (TGF)-β1 induces cell cycle arrest or apoptosis; however, the role of TGF-β1 in promoting cancer cell proliferation has not been explored in detail. The purpose of this study was to identify the effect of TGF-β1 on OSCC cell proliferation. Study Design Using both human OSCC samples and cell lines (UMSCC38 and UMSCC11B), we assessed protein, mRNA, gene expression, and protein–DNA interactions during OSCC progression. Results Our results showed that TGF-β1 increased OSCC cell proliferation by upregulating the expression of ΔNp63 and c-Myc oncogenes. Although the basal OSCC cell proliferation is sustained by activating ΔNp63, increased induction of c-Myc causes unregulated OSCC cell proliferation. Following induction of the cell cycle by ΔNp63 and c-Myc, cancer cells that halt c-Myc activity undergo epithelial mesenchymal transition or invasion while those that continue to express ΔNp63/c-Myc undergo unlimited progression through the cell cycle. Conclusions OSCC proliferation is manifested by the induction of c-Myc in response to TGF-β1 signaling, which is essential for OSCC growth. Our data highlight the potential role of TGF-β1 in the induction of cancer progression and invasion of OSCC.

UR - http://www.scopus.com/inward/record.url?scp=84991108585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991108585&partnerID=8YFLogxK

U2 - 10.1016/j.oooo.2016.05.018

DO - 10.1016/j.oooo.2016.05.018

M3 - Article

C2 - 27567435

AN - SCOPUS:84991108585

VL - 122

SP - 460-482.e4

JO - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

JF - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

SN - 2212-4403

IS - 4

ER -